Jacquelyn Sumer

Insider Reports History

Entity
Individual
Location
C/O Genocea Biosciences, Inc., 100 Acorn Park Drive 5 Th Floor, Cambridge, MA
Signature
/s/ Jacquelyn Sumer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jacquelyn Sumer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Therapeutics, Inc. Chief Legal Officer Common Stock 90.7K $1.03M $11.41 Dec 18, 2024 Direct
GENOCEA BIOSCIENCES, INC. CHIEF LEGAL & COMPLIANCE OFF Common Stock 43K $53.8K $1.25 Jun 1, 2022 Direct
Cullinan Oncology, Inc. Chief Legal Officer Stock Option (Right to Buy) 100K Feb 22, 2024 Direct

Insider Reports Filed by Jacquelyn Sumer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Therapeutics, Inc. Dec 18, 2024 1 -$39.7K 4 Dec 20, 2024 Chief Legal Officer
CGEM Cullinan Oncology, Inc. Feb 22, 2024 2 $0 4 Feb 23, 2024 Chief Legal Officer
CGEM Cullinan Oncology, Inc. Dec 21, 2023 1 -$11.9K 4 Dec 22, 2023 Chief Legal Officer
CGEM Cullinan Oncology, Inc. Dec 18, 2023 1 -$2.38K 4 Dec 20, 2023 Chief Legal Officer
CGEM Cullinan Oncology, Inc. Jun 20, 2023 1 -$3.77K 4 Jun 21, 2023 Chief Legal Officer
CGEM Cullinan Oncology, Inc. May 18, 2023 1 -$2.55K 4 May 19, 2023 Chief Legal Officer
CGEM Cullinan Oncology, Inc. Apr 18, 2023 1 -$3.11K 4 Apr 20, 2023 Chief Legal Officer
CGEM Cullinan Oncology, Inc. Mar 20, 2023 1 -$3.45K 4 Mar 27, 2023 Chief Legal Officer
CGEM Cullinan Oncology, Inc. Feb 17, 2023 2 $0 4 Feb 21, 2023 Chief Legal Officer
CGEM Cullinan Oncology, Inc. Aug 15, 2022 1 $0 4 Aug 16, 2022 Chief Legal Officer
CGEM Cullinan Oncology, Inc. Aug 15, 2022 0 $0 3 Aug 16, 2022 Chief Legal Officer
GNCA GENOCEA BIOSCIENCES, INC. Jun 1, 2022 1 -$150 4 Jun 2, 2022 CHIEF LEGAL & COMPLIANCE OFF
GNCA GENOCEA BIOSCIENCES, INC. Mar 15, 2022 2 $0 4 Mar 17, 2022 CHIEF LEGAL & COMPLIANCE OFF